TWO-YEAR CLINICAL RESPONSE TO BRODALUMAB, AN ANTI-IL-17 RECEPTOR ANTIBODY, IN PATIENTS WITH PSORIATIC ARTHRITIS

被引：2
|
作者：
Mease, P. [1 ,2 ]
Genovese, M. C. [3 ]
Greenwald, M. W. [4 ]
Ritchlin, C. T. [5 ]
Beaulieu, A. [6 ]
Deodhar, A. [7 ]
Newmark, R. [8 ]
Feng, J. [8 ]
Erondu, N. [8 ]
Nirula, A. [8 ]
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Stanford Univ, Palo Alto, CA 94304 USA
[4] Desert Med Adv, Palm Desert, OH USA
[5] Univ Rochester, Med Ctr, Rochester, OH USA
[6] Univ Laval, Laval, PQ, Canada
[7] Oregon Hlth & Sci Univ, Portland, OR USA
[8] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.3489
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0175
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [41] Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis
    Constantin, Tamas
    Foeldvari, Ivan
    Vojinovic, Jelena
    Horneff, Gerd
    Burgos-Vargas, Ruben
    Nikishina, Irina
    Akikusa, Jonathan D.
    Avcin, Tadej
    Chaitow, Jeffrey
    Koskova, Elena
    Lauwerys, Bernard R.
    Penades, Inmaculada Calvo
    Flato, Berit
    Gamir, Maria Luz
    Huppertz, Hans-Iko
    Raad, Juan Jose Jaller
    Jarosova, Katerina
    Anton, Jordi
    Macku, Marie
    Escalante, William J. Otero
    Rutkowska-Sak, Lidia
    Trauzeddel, Ralf
    Velez-Sanchez, Patricia J.
    Wouters, Carine
    Wajdula, Joseph
    Zang, Chuanbo
    Bukowski, Jack
    Woodworth, Deborah
    Vlahos, Bonnie
    Martini, Alberto
    Ruperto, Nicolino
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (04) : 816 - 824
  • [42] DISCONTINUATION OF ETANERCEPT IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: TWO-YEAR OUTCOME
    Urata, Y.
    Nakamura, Y.
    Motomura, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 525 - 525
  • [43] Infliximab therapy in psoriatic arthritis patients with severe psoriasis. A two-year follow-up.
    Voulgari, Paraskevi V.
    Venetsanopoulou, Aliki I.
    Epagelis, Efstratios K.
    Alamanos, Yannis
    Takalou, Ioanna
    Drosos, Alexandros A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S725 - S726
  • [44] Anti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial
    Papp, Kim A.
    Reid, Cathy
    Foley, Peter
    Sinclair, Rod
    Salinger, David H.
    Williams, Gary
    Dong, Hua
    Krueger, James G.
    Russell, Chris B.
    Martin, David A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (10) : 2466 - 2469
  • [45] A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
    Martin, David A.
    Churchill, Melvin
    Felipe Flores-Suarez, Luis
    Cardiel, Mario H.
    Wallace, Daniel
    Martin, Richard
    Phillips, Kristine
    Kaine, Jeffrey L.
    Dong, Hua
    Salinger, David
    Stevens, Erin
    Russell, Chris B.
    Chung, James B.
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [46] A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
    David A Martin
    Melvin Churchill
    Luis Felipe Flores-Suarez
    Mario H Cardiel
    Daniel Wallace
    Richard Martin
    Kristine Phillips
    Jeffrey L Kaine
    Hua Dong
    David Salinger
    Erin Stevens
    Chris B Russell
    James B Chung
    Arthritis Research & Therapy, 15
  • [47] Regulatory Role of IL-23 and Its Receptor System in Spondyloarthritis and Its Therapeutic Relevance in anti-IL-17 Failure Patients
    Raychaudhuri, Siba
    Raychaudhuri, Smritikana
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [48] Association of anti-cyclic citrullinated peptide antibody with clinical features in patients with psoriatic arthritis
    Hagiwara, Shinya
    Tsuboi, Hiroto
    Terasaki, Toshihiko
    Terasaki, Mayu
    Toko, Hirofumi
    Shimizu, Masaru
    Honda, Fumika
    Yagishita, Mizuki
    Ohyama, Ayako
    Takahashi, Hiroyuki
    Yokosawa, Masahiro
    Asashima, Hiromitsu
    Kondo, Yuya
    Matsumoto, Isao
    Sumida, Takayuki
    MODERN RHEUMATOLOGY, 2020, 30 (02) : 365 - 372
  • [49] CLINICAL ASSOCIATIONS OF THE IL-17A, IL-17F AND NFKB-1 GENE POLYMORPHISMS IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS
    Sokolik, R.
    Swierkot, J.
    Gebura, K.
    Wysoczanska, B.
    Bielanska, M.
    Korman, L.
    Wiland, P.
    Bogunia-Kubik, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1056 - 1057
  • [50] Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents
    Mastorino, Luca
    Dapavo, Paolo
    Macagno, Nicole
    Ortoncelli, Michela
    Verrone, Anna
    Stroppiana, Elena
    Cariti, Caterina
    Susca, Sara
    Siliquini, Niccolo
    di Corteranzo, Isotta Giunipero
    Quaglino, Pietro
    Ribero, Simone
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (12) : 1735 - 1739
12345